![Rolf Soderstrom](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 193 600 $ in data 31/07/2026
Rolf Kristian Soderstrom is currently an Independent Non-Executive Director at BioPharma Credit PLC since 2020, an Independent Outside Director at Nxera Pharma Co., Ltd. since 2020, and a Member of The Institute of Chartered Accountants in England & Wales.
Former roles include Director-Corporate Finance at Cable & Wireless Ltd. from 2001 to 2004, Finance Director-Divisional at Cobham Ltd. from 2004 to 2007, Chief Financial Officer at Protherics Plc from 2007 to 2008, Chief Financial Officer & Executive Director at BTG Ltd. from 2008 to 2018, Senior Independent Non-Executive Director at Ergomed Group Ltd., and Chief Financial Officer at Syncona Investment Management Ltd. and Syncona Partners LLP.
Education includes undergraduate studies at University College London.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 31/12/2025 | 200.000 ( 0,02% ) | 193 600 $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| NXERA PHARMA CO., LTD. | Direttore/Membro del Consiglio | 25/03/2020 |
| BIOPHARMA CREDIT PLC | Direttore/Membro del Consiglio | 16/09/2020 |
Institute of Chartered Accountants in England & Wales
 Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services Operates as a membership organization for chartered accountant firm and students | Corporate Officer/Principal | - |
| Società | Posizione | Fine |
|---|---|---|
| ERGOMED | Direttore/Membro del Consiglio | 30/09/2021 |
| BTG | Direttore Finanziario/CFO | 01/01/2018 |
Protherics Plc
 Protherics Plc Pharmaceuticals: MajorHealth Technology Researches, develops, and manufactures biopharmaceutical products | Direttore Finanziario/CFO | 30/11/2008 |
| COBHAM | Corporate Officer/Principal | 01/01/2007 |
Cable & Wireless Ltd.
 Cable & Wireless Ltd. Wireless TelecommunicationsCommunications Provides international telecommunications services and offers enterprise and carrier solutions | Direttore Finanziario/CFO | 01/01/2004 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 11 |
|---|---|
Cable & Wireless Ltd.
Cable & Wireless Ltd. Wireless TelecommunicationsCommunications Provides international telecommunications services and offers enterprise and carrier solutions | Communications |
Protherics Plc
Protherics Plc Pharmaceuticals: MajorHealth Technology Researches, develops, and manufactures biopharmaceutical products | Health Technology |
Cobham Ltd.
 Cobham Ltd. Aerospace & DefenseElectronic Technology Designs and manufactures intelligent hardware for defense, aerospace & space markets | Electronic Technology |
BTG Ltd.
 BTG Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies drugs used in the treatment of neurological disorders | Health Technology |
Institute of Chartered Accountants in England & Wales
Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services Operates as a membership organization for chartered accountant firm and students | Commercial Services |
University College London
 University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nxera Pharma Co., Ltd.
 Nxera Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops bio pharmaceutical products | Health Technology |
Syncona Partners LLP
 Syncona Partners LLP Investment ManagersFinance Syncona Partners invests in companies located across the globe. The firm focuses on life science businesses and therapeutic areas.. It participates in early stage capital requirements. | Finance |
Ergomed Plc
 Ergomed Plc BiotechnologyHealth Technology Engages in research and development of drugs for oncology & rare diseases | Health Technology |
BioPharma Credit PLC
 BioPharma Credit PLC Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust | Miscellaneous |
Syncona Investment Management Ltd.
 Syncona Investment Management Ltd. Investment ManagersFinance Syncona aims to build a sustainable, diverse portfolio of 15-20 companies focused on delivering transformational treatments to patients in truly innovative areas of healthcare, through which they are seeking to deliver strong risk-adjusted returns for shareholders. The firm takes a long-term view, underpinned by a strategic capital base which enables them to maintain significant ownership positions in their companies and provides them with control and flexibility over the management of their portfolio. | Finance |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
